Search

Patents Prosecuted

Application numberTitle of the patentIPCFiling DateDecision Date
17454243 METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS A61K Nov 8, 2021 Nov 12, 2023
17452963 ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION A61P, A61K Oct 28, 2021 Jan 4, 2024
17515228 TISSUE EXPANSION DEVICE A61B, A61F Oct 28, 2021
17515228 TISSUE EXPANSION DEVICE A61B, A61F Oct 28, 2021
17505048 ANIMAL PROTEIN-FREE PHARMACEUTICAL COMPOSITIONS A61K Oct 18, 2021 Nov 30, 2022
17505537 Process and system for obtaining botulinum neurotoxin B01D, C07K, C12N, C12P, C12R Oct 18, 2021 May 9, 2022
17449031 STABILIZED OMEGA-3 OPHTHALMIC COMPOSITIONS A61K Sep 26, 2021
17408055 PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANTS AND METHODS OF USE THEREOF A61K, A61F Aug 19, 2021 Oct 10, 2023
17400815 COMPOSITIONS FOR THE TREATMENT OF DRY EYE A61K Aug 11, 2021 Nov 3, 2023
17399504 EYE DROP FORMULATION WITH ENHANCED PROPERTIES BY COMBINING SODIUM HYALURONATE WITH CARBOXYMETHYLCELLULOSE A61K Aug 10, 2021
17384388 Animal protein-free pharmaceutical compositions A61K Jul 22, 2021 Mar 28, 2022
17443083 INTRAOCULAR IMPLANT WITH HIGH LOADING OF A PROSTAMIDE A61F, A61K, C08L Jul 19, 2021
17376757 Sodium chlorite compositions with enhanced antimicrobial efficacy and reduced toxicity A61K, A61P Jul 14, 2021 Aug 28, 2023
17376416 Immuno-based botulinum toxin serotype A activity assays G01N, C12Q, C07K Jul 14, 2021 May 16, 2022
18015136 TISSUE EXPANSION DEVICE WITH FLUID COLLECTION A61B, A61M Jul 8, 2021
18004755 POSTERIOR CHAMBER PLACEMENT OF SUSTAINED RELEASE IMPLANT A61K, A61F Jul 8, 2021
17364470 USE OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION A61K, A61P Jun 29, 2021
17347317 Injection paradigm for administration of botulinum toxins A61K, C07K Jun 13, 2021 Nov 20, 2023
17341325 HEAVY CHAIN ONLY ANTIBODIES TO PDGF A61K, C07K Jun 6, 2021 Jun 27, 2023
17340720 Process and system for obtaining botulinum neurotoxin C12R, C12P, B01D, C12N, C07K Jun 6, 2021 Dec 20, 2021
Menu